{
    "SPADE_UN_24477": {
        "Sequence Information": {
            "Peptide Name": "EBOV-GP (610-639)[T620K,Q625K]-C",
            "Sequence": "IEPHDWTKNIKDKIDKIIHDFVDKTLPDQGX",
            "Sequence Length": 31,
            "Biological Activity": [
                "Antiviral",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Virus entry",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "Q05320",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/Q05320",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.",
                    "Pubmed ID": "31473342",
                    "Reference": "Antiviral Res. 2019;171:104592",
                    "Author": "Pessi A, Bixler SL, Soloveva V, Radoshitzky S",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31473342"
                }
            ],
            "SPADE ID": "SPADE_UN_24477",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_24474",
                    "Similarity": 1.0,
                    "Sequence": "DWTKNIKDKIDKIIHDFVDK"
                },
                {
                    "SPADE_ID": "SPADE_UN_24475",
                    "Similarity": 1.0,
                    "Sequence": "DWTKNIKDKIDKIIHDFVDKTLPDQG"
                },
                {
                    "SPADE_ID": "SPADE_UN_24476",
                    "Similarity": 1.0,
                    "Sequence": "DWTKNIKDKIDKIIHDFVDKTLPDQG"
                }
            ],
            "Hemolytic Activity": "Human embryonic kidney HEK293T cells:50% Cytotoxicity=>=25 µM",
            "Target Organism": "Ebola virus EBOV(IC50 I=1.90±0.28µM),Ebola virus EBOV(IC90 I=9.44µM),Human cervical carcinoma HeLa(50-60% Cytotoxicity=>25µM),Ebola virus EBOV-GP PsV(IC50 E=0.60±0.20µM),Ebola virus EBOV-GP PsV(IC90=6.15µM),Marburg virus MARV-GP PsV(IC50 E=8.45±1.49µM),Marburg virus MARV-GP PsV(IC90=33.36µM)"
        }
    }
}